Unresectable Synovial Sarcoma
5 clinical trials · Condition
◉ Watch Unresectable Synovial Sarcoma
| Record | Firm | Date |
|---|---|---|
| Testing the Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare Cancers (NCT07686367) | National Cancer Institute (NCI) | 2026-09-11 |
| Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma (NCT05711615) | National Cancer Institute (NCI) | 2024-02-06 |
| Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma (NCT03063632) | National Cancer Institute (NCI) | 2017-12-14 |
| Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1 (NCT02650986) | Roswell Park Cancer Institute | 2017-07-14 |
| Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery (NCT03009201) | OHSU Knight Cancer Institute | 2017-03-10 |
Track Unresectable Synovial Sarcoma automatically
Every clearance here is in the API, with alerts when new ones post.